Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.56 |
| ▸ | FABP3 | P05413 | 1/20 | 0.43 |
| ▸ | LMNA | P02545 | 2/20 | 0.33 |
| ▸ | AKT1 | P31749 | 2/20 | 0.33 |
| ▸ | ESR1 | P03372 | 1/20 | 0.33 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.33 |
| ▸ | CDC25A | P30304 | 1/20 | 0.33 |
| ▸ | AGTR1 | P30556 | 1/20 | 0.33 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.33 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.33 |
| ▸ | P2RY10 | O00398 | 4/20 | 0.32 |
| ▸ | GPR34 | Q9UPC5 | 2/20 | 0.32 |
| ▸ | MEN1 | O00255 | 2/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.32 |
| ▸ | S1PR1 | P21453 | 1/20 | 0.32 |
| ▸ | PRKD3 | O94806 | 1/20 | 0.32 |
| ▸ | PRKCG | P05129 | 1/20 | 0.32 |
| ▸ | PRKCB | P05771 | 1/20 | 0.32 |
| ▸ | PRKCA | P17252 | 1/20 | 0.32 |
| ▸ | PRKCH | P24723 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5019714 | 0.89 | SMN1; SMN2 (0.69) | SMN1; SMN2FABP3LMNAAKT1ESR1 | |
| SCHEMBL8899300 | 0.89 | SMN1; SMN2 (0.69) | SMN1; SMN2FABP3LMNAAKT1ESR1 | |
| SCHEMBL157824 | 0.89 | SMN1; SMN2 (0.69) | SMN1; SMN2FABP3LMNAAKT1ESR1 | |
| SCHEMBL101267 | 0.89 | SMN1; SMN2 (0.69) | SMN1; SMN2FABP3LMNAAKT1ESR1 | |
| SCHEMBL27168721 | 0.89 | SMN1; SMN2 (0.69) | SMN1; SMN2FABP3LMNAAKT1ESR1 | |
| Glycerin SCHEMBL28844001 | 0.88 | SMN1; SMN2 (0.68) | SMN1; SMN2FABP3LMNAAKT1ESR1 | |
| Glycerin SCHEMBL28844000 | 0.88 | SMN1; SMN2 (0.68) | SMN1; SMN2FABP3LMNAAKT1ESR1 | |
| Choline SCHEMBL29922745 | 0.85 | SMN1; SMN2 (0.64) | SMN1; SMN2FABP3LMNAAKT1ESR1 | |
| SCHEMBL10013704 | 0.81 | SMN1; SMN2 (0.50) | SMN1; SMN2FABP3LMNAAKT1ESR1 | |
| SCHEMBL14950221 | 0.80 | SMN1; SMN2 (0.57) | SMN1; SMN2FABP3LMNAAKT1ESR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20170037067-A1 | NEW LIPOPHENOL COMPOUNDS AND USES THEREOF | CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (CNRS) (FR) | 2017-02-09 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170037067-A1 | NEW LIPOPHENOL COMPOUNDS AND USES THEREOF | LCLAT1, CBR1, LPO | SMN1; SMN2 4862/4885FABP3 854/4885LMNA 2350/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.